Stay updated on Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab plus bevacizumab is displayed, with study details, participant criteria, treatment plan, outcome measures, and supporting documents.
    Difference
    59%
    Check dated 2026-11-07T15:56:05.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T16:29:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T18:49:24.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2, while the study page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T18:21:59.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T19:16:28.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study record content and preventing users from viewing details about the trial. Access appears blocked due to server configuration or permissions, affecting the page's primary purpose until resolved.
    Difference
    20%
    Check dated 2026-09-19T19:05:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.